Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting

Niscola Pasquale; Tendas Andrea; Cupelli Luca; Giovannini Marco; Piccioni Daniela; Scaramucci Laura; Dentamaro Teresa; Del Poeta Giovanni; de Fabritiis Paolo

首页> 外文期刊>Acta Haematologica >Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting

【24h】

Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting

机译：阿扎胞苷治疗失败后继发于骨髓增生异常综合症和慢性粒细胞单核细胞白血病的急性髓细胞白血病的不良结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Acta Haematologica》 |2015年第1期|共3页
作者
Niscola Pasquale; Tendas Andrea; Cupelli Luca; Giovannini Marco; Piccioni Daniela; Scaramucci Laura; Dentamaro Teresa; Del Poeta Giovanni; de Fabritiis Paolo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting [J] . Niscola Pasquale, Tendas Andrea, Cupelli Luca, Acta Haematologica . 2015,第1期

机译：阿扎胞苷治疗失败后继发于骨髓增生异常综合症和慢性粒细胞单核细胞白血病的急性髓细胞白血病的不良结果
2. Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study) [J] . Wehmeyer Jürgen, Zaiss Matthias, Losem Christoph, European Journal of Haematology . 2018,第6期

机译：氮杂氨酸（PIAZA研究）治疗骨髓增生综合征患者患者患者患者患者疗效的影响
3. A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia [J] . Chutima Kunacheewa, Pakaporn Thongthang, Patompong Ungprasert, Hematology . 2019,第1期

机译：对急性髓性白血病患者，骨髓增强综合征和慢性骨髓细胞白血病患者的氮杂氨酸 - 加莱甲二胺醛治疗疗效和不良事件的系统评价和荟萃分析
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level [D] . Chen, Jiahao. 2018

机译：在干细胞水平上骨髓增生异常综合征进展为急性髓细胞性白血病
6. Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia [O] . Guillermo Garcia-Manero, Steven D. Gore, Christopher Cogle, -1

机译：口服阿扎胞苷在骨髓增生异常综合症慢性粒单核细胞白血病和急性髓样白血病中的I期研究
7. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias [O] . F Damm, R Itzykson, O Kosmider, 2013

机译：658例骨髓间增生患者患者的SetBP1突变，慢性骨髓细胞白血病和继发性敏感白血病

Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting

著录项

相似文献

相关主题

期刊订阅